MAIA - MAIA Biotechnology Inc P/S multiplikatori

MAIA Bio (MAIA) tovar belgisi

MAIA Biotechnology (MAIA) rivojlanishi, P/S koeffitsiyenti grafigi bilan tasdiqlanganidek, test natijalari va mablag'larning sarflanish sur'atiga (burn rate) kritik darajada bog'liq. Shu bilan birga, eng so'nggi daraja qiymatini ifodalaydi. O'simta qarshiligiga qarshi kurashish uchun telomerazaga yo'naltirilgan agentlarning yaratilishi ushbu xavflarni yumshatadi. Model o'pka saratoni terapiyasiga tayanadi, bunda kelgusidagi to'lovlar sug'urta tuzilmalari va davlat jamg'armalari tomonidan ta'minlanadi.

MAIA (MAIA Biotechnology Inc) Narxning daromadga nisbati tarixi 04.07.2022dan 13.11.2026gacha

MAIA Biotechnology Inc (MAIA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning umumiy tahlili:MAIABiotech.com, MAIA
MAIA Biotech ishlab chiqargan mahsulot

P/S ko'rsatkichi biznesning bozor qiymatini uning yillik daromadiga nisbatan o'lchaydi va investor sotuvlarning bir birligi uchun qancha premium to'lashga tayyorligini aniqlaydi. MAIA Biotechnology (MAIA) kompaniyasidagi qattiq o'sma terapiyasi dasturlarining diversifikatsiyasi risklarni kamaytiradi, bu esa baholash barqarorligini ta'minlashi kerak. GURU.Markets platformasida daromad multiplikatorini tahlil qilish orqali aktiv uchun barqaror qiymat koridorini aniqlash mumkin. Jori narxlar dinamikasi kompaniyaning bozor pozitsiyasini fundamental yo'qotishga qarshi himoyasini real vaqt rejimida baholash imkonini beradi.

Raqobatdosh kompaniyalar

Kapitalizatsiyaning daromadga nisbati immunitybio.com IBRX|Immunocore - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Janux Therapeutics Inc JANX|RCUS - Narxning daromadga nisbati|ZYME (Zymeworks Biopharmaceuticals) - Kapitalizatsiya va daromad nisbati|Tango Therapeutics (TNGX) - Narxning daromadga nisbati|Sotuvga nisbatan narx iovance.com (IOVA)|Kapitalizatsiyaning daromadga nisbati IMTX|XNCR - Narx/daromad multiplikatori|Kapitalizatsiyaning daromadga nisbati CMPX (Compass Bio)|Kapitalizatsiyaning sotish hajmiga nisbati REPL|P/S multiplikatori LYEL (Lyell Immunopharma)|Bozor kapitallashuvining daromadga nisbati IPHA|Pyxis - P/S multiplikatori|Sotuvga nisbatan narx Compugen Ltd.|IO Biotech Corp (IOBT) - Narxning daromadga nisbati|Sutro Biopharma, Inc - Bozor kapitallashuvining daromadga nisbati|INKT (MiNK Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Werewolf|Narxning daromadga nisbati Immix Biopharma, Inc. (IMMX)|ALXO: Narxning sotuvga nisbati|Cue Biopharma, Inc. - Kapitalizatsiyaning daromadga nisbati|PDS Biotech (PDSB) - Sotuvga nisbatan narx|SONN - Narxning daromadga nisbati|liminatuspharma.com (LIMN) - Kapitalizatsiyaning daromadga nisbati|LVTX: P/S multiplikatori|NextCure Inc (NXTC) - P/S multiplikatori|LPTX (Leap Therapeutics Inc) - P/S multiplikatori|Intensity Tx (INTS) - Narx/daromad koeffitsiyenti|P/S multiplikatori SNSE|P/S multiplikatori therivabio.com (TOVX)|Gritstone bio - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KA|NexImmune Corp - P/S multiplikatori|TSBX: Narxning daromadga nisbati|VCNX: P/S multiplikatori|HARP - Narx/daromad koeffitsiyenti